Deutsche Bank said Gilead(NASDAQ:GILD)’s Atripla recall is not an issue. The firm said Gilead proactively issued the recall following a typical quality check that found small particles and notes the company has multiple manufacturers for Atripla. Management said it was a minor issue and that Atripla supply is more than enough. Shares are Buy rated…
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -3.34% in last session and finished the day at $8.69. Traded volume was 1,200.00 shares in the last session and the average volume of the stock remained 26.48 million shares….
Strides Arcolab, announced that it has entered into a licensing agreement with Gilead Sciences Inc. (NASDAQ:GILD)under which Gilead has extended non-exclusive rights to Strides to manufacture and distribute Tenofovir Alafenamide (TAF), both as a single agent product and in combination with other drugs. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin…
The PGA Tour and The Charles Schwab Corporation (NYSE:SCHW) have reached an agreement to extend the sponsorship of the Champions Tour’s season-long points race and season-ending tournament for 20 years — the longest marketing agreement the Tour has ever signed with a sponsor. The Charles Schwab Corporation (NYSE:SCHW) belongs to Financial sector. Its net profit…
On Dec. 15, Gilead Sciences Inc. (NASDAQ:GILD) announced that Philippe C. Bishop, MD, will join the company as Senior Vice President, Hematology and Oncology Therapeutics. In this position, Dr. Bishop will report to John McHutchison, MD, Executive Vice President, Clinical Research and will have responsibility for Gilead’s programs in oncology. Dr. Bishop will also join…
MetLife, Inc. (NYSE:MET) issued the following statement after the company was notified by the Financial Stability Oversight Council (FSOC) that it has been designated a non-bank systemically important financial institution (SIFI): “We are disappointed in the FSOC decision. We continue to believe that MetLife is not systemically important under the Dodd-Frank Act’s criteria, and the…
